Canadian CANNAINVESTOR Magazine July / August 2019 | Page 169

SCIENCE, PERFORMANCE, COMPASSION. If you have not done so yet, I urge you to review our May issue, as Canntab Therapeutics was our feature company. The magazine is loaded with information on Canntab and also includes a great interview with Jeff Renwick, CEO of Canntab. When you do review it, you will notice the pillars of Canntab: SCIENCE, PERFORMANCE, COMPASSION. The very reasons I myself invested in the cannabis sector many years ago now.

The science and compassion at Canntab are unmatched, being the only company in North America to have produced hard pill formulations of cannabinoid and terpenoid blends in exacting doses. You might think, well yes that is great, but there are countless pills available now within both the medical and recreational cannabis spaces. The difference is, a hard pill has far better shelf life and more precise dosage. But the real benefits are attributed to CannTab’s extended release technology and the high bioavailability of their hard pills when comparing to other alternative delivery methods.

169